Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/11/2019
SIETES contiene 92833 citas

 
 
 1 a 20 de 81 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Catalá-López F, Tobías A. Síntesis de la evidencia clínica y metaanálisis en red con comparaciones indirectas. Med Clin (Barc) 2013;140:182-7. [Ref.ID 94933]
2. Cita con resumen
Chan A-W, Telzlaff JM, Altman DG, Laupacis A, Gotzche PC, Krieza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med 2013;158:200-7. [Ref.ID 94901]
3. Cita con resumen
4.Tiene citas relacionadas Cita con resumen
Mulla SM, Scott IA, Jackevicius CA, You JJ, Guyatt GH. How to use a noninferiority trial: Users' guides to the medical literature. JAMA 2012;308:2605-11. [Ref.ID 94278]
5. Cita con resumen
Takahashi Y, Nishida Y, Asai S. Utilization of health care databases for pharmacoepidemiology. Eur J Clin Pharmacol 2012;68:123-9. [Ref.ID 92327]
6. Cita con resumen
Lynn E, Layton D, Shakir S. New postgraduate qualifications in pharmacovigilance from The Drug Safety Research Unit in the UK. Drug Saf 2011;34:89-91. [Ref.ID 89980]
7. Cita con resumen
Hutcheon JA, Chiolero A, Hanley JA. Random measurement error and regression dilution bias. BMJ 2010;340:1402-6. [Ref.ID 88747]
8. Cita con resumen
Bassler D, Briel M, Montori VM, Lane M, Glasziou P, Zhou Q, Heels Ansdell D, Walter SD, Guyatt GH, and the STOPIT-2 Study Group. Stopping randomized trials early for benefit and estimation of treatment effects. Systematic review and meta-regression analysis. JAMA 2010;303:1180-7. [Ref.ID 88155]
9. Cita con resumen
Jönsson AK, Hakkarainen KM, Spigset O, Druid H, Hiselius A, Hägg S. Preventable drug related mortality in a Swedish population. Pharmacoepidemiol Drug Saf 2010;19:211-5. [Ref.ID 87697]
10. Cita con resumen
Eldridge S, Kerry S, Torgerson DJ. Bias in identifying and recruiting participants in cluster randomised trials: what can be done?. BMJ 2010;340:36-9. [Ref.ID 87670]
11.
Anónimo. Teaching responsible conduct of research. Lancet 2009;374:1568. [Ref.ID 87104]
12. Cita con resumen
Anónimo. Understanding statistical terms: 3. Drug Ther Bull 2009;47:59-60. [Ref.ID 85827]
13.Tiene citas relacionadas Cita con resumen
Vandenbroucke JP. The HRT controversy: observational studies and RCTs fall in line. Lancet 2009;373:1233-5. [Ref.ID 85612]
14. Cita con resumen
Moore ND. Textbook of pharmacoepidemiology. N Engl J Med 2007;357:1669-70. [Ref.ID 81315]
15. Cita con resumen
Suissa S. Immortal time bias in observational studies of drug effects. Pharmacoepidemiol Drug Saf 2007;16:241-9. [Ref.ID 79570]
17. Cita con resumen
Cordell HJ, Clayton DG. Genetic association studies. Lancet 2005;366:1121-31. [Ref.ID 74976]
18. Cita con resumen
Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet 2005;365:1429-33. [Ref.ID 73449]
19.Tiene citas relacionadas Cita con resumen
Summerskill W. Evidence-based practice and the individual. Lancet 2005;365:13-4. [Ref.ID 72414]
20.Tiene citas relacionadas Cita con resumen
Brotman DJ. Observational versus randomised trial evidence. Authors' reply. Lancet 2004;364:757. [Ref.ID 71215]
Seleccionar todas
 
 1 a 20 de 81 siguiente >>